Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.90
-0.0600-0.75%
Volume:13.97K
Turnover:110.08K
Market Cap:53.69M
PE:-0.69
High:8.07
Open:7.93
Low:7.81
Close:7.96
Loading ...

Atara reduction in workforce to impact 50% of current employees

TIPRANKS
·
28 Jan

Atara Biotherapeutics Inc - to Reduce Workforce by 50%

THOMSON REUTERS
·
28 Jan

Atara Biotherapeutics Faces Uncertainty Amid FDA Clinical Hold and Financing Needs, Resulting in Hold Rating

TIPRANKS
·
22 Jan

Atara Biotherapeutics price target lowered to $5 from $10 at Stifel

TIPRANKS
·
22 Jan

Atara Biotherapeutics Shares Tumble After FDA Places Clinical Hold on Investigational New Drug Applications

MT Newswires Live
·
22 Jan

Rodman & Renshaw Downgrades Atara Biotherapeutics to Neutral From Buy, $7 Price Target

MT Newswires Live
·
22 Jan

Atara Biotherapeutics downgraded to Neutral from Buy at Rodman & Renshaw

TIPRANKS
·
22 Jan

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

Benzinga
·
22 Jan

Atara Biotherapeutics Shares Fall 4.7% After FDA Puts Clinical Hold on Co's Cancer Therapy Trials

THOMSON REUTERS
·
21 Jan

BUZZ-Atara Biotherapeutics falls after FDA puts clinical hold on cancer therapy trials

Reuters
·
21 Jan

Atara's New Drug Applications Placed on Hold by FDA

Dow Jones
·
21 Jan

Atara Biotherapeutics Shares Down 4.4% Premarket After US FDA Places Clinical Hold on Cancer Therapy Trials

THOMSON REUTERS
·
21 Jan

BRIEF-Atara Biotherapeutics Provides Update On Clinical Programs For Ebvallo™ And Ata3219

Reuters
·
21 Jan

Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219

TIPRANKS
·
21 Jan

US FDA puts clinical hold on Atara's trials for cancer cell therapies

Reuters
·
21 Jan

Atara Biotherapeutics Inc: FDA Has Placed a Clinical Hold on Atara's Active Investigational New Drug (Ind) Applications

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Inc: Screening and Enrollment of New Participants in Both Programs Have Been Paused

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Provides Update on Clinical Programs Related to Ebvallo™ (Tabelecleucel) and ATA3219

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219

Business Wire
·
21 Jan

ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer Candidate

Zacks
·
17 Jan